NCRNA00120 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.930400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.437800E-01
Normal-vs-Stage2
5.004200E-01
Normal-vs-Stage3
4.380200E-01
Normal-vs-Stage4
6.458800E-01
Stage1-vs-Stage2
4.182000E-01
Stage1-vs-Stage3
8.762800E-01
Stage1-vs-Stage4
1.388980E-01
Stage2-vs-Stage3
4.305000E-01
Stage2-vs-Stage4
6.118500E-02
Stage3-vs-Stage4
1.233380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.977200E-01
Normal-vs-AfricanAmerican
5.065000E-01
Normal-vs-Asian
4.269200E-01
Caucasian-vs-AfricanAmerican
9.535400E-01
Caucasian-vs-Asian
1.605570E-01
AfricanAmerican-vs-Asian
3.375600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.950600E-01
Normal-vs-Female
4.906600E-01
Male-vs-Female
8.684000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.520400E-01
Normal-vs-Age(41-60Yrs)
5.160800E-01
Normal-vs-Age(61-80Yrs)
4.831000E-01
Normal-vs-Age(81-100Yrs)
4.905600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.024400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.485000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.260800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.726800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.201200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.248600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.210400E-01
Normal-vs-Daily Drinker
4.579200E-01
Normal-vs-Weekly Drinker
4.430800E-01
Normal-vs-Occasional Drinker
4.932600E-01
Normal-vs-Social Drinker
4.661600E-01
Non Drinker-vs-Daily Drinker
2.498200E-01
Non Drinker-vs-Weekly Drinker
1.072240E-01
Non Drinker-vs-Occasional Drinker
6.474400E-01
Non Drinker-vs-Social Drinker
2.464800E-01
Daily Drinker-vs-Weekly Drinker
7.756600E-01
Daily Drinker-vs-Occasional Drinker
5.538000E-01
Daily Drinker-vs-Social Drinker
8.403400E-01
Weekly Drinker-vs-Occasional Drinker
3.622000E-01
Weekly Drinker-vs-Social Drinker
5.365400E-01
Occasional Drinker-vs-Social Drinker
6.282000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.672200E-01
Normal-vs-Grade 2
8.300300E-02
Normal-vs-Grade 3
6.270200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.107600E-01
Grade 1-vs-Grade 3
1.255580E-01
Grade 1-vs-Grade 4
3.672200E-01
Grade 2-vs-Grade 3
5.545800E-01
Grade 2-vs-Grade 4
8.300300E-02
Grade 3-vs-Grade 4
6.270200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.105200E-01
Normal-vs-NonDiabetic
4.720000E-01
Diabetic-vs-NonDiabetic
2.942000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.757000E-01
Normal-vs-NoPancreatitis
4.856800E-01
Pancreatitis-vs-NoPancreatitis
8.351000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.772600E-01
Normal-vs-N1
5.039400E-01
N0-vs-N1
3.648000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.635800E-01
Normal-vs-TP53-NonMutant
4.392200E-01
TP53-Mutant-vs-TP53-NonMutant
5.132000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
